Aardvark Therapeutics (AARD) Earnings Date & Reports
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AARD is expected to report earnings to rise 16.67% to -76 cents per share on December 03
Q3'25
Est.
$-0.77
Q2'25
Beat
by $0.04
The last earnings report on August 13 showed earnings per share of -66 cents, beating the estimate of -69 cents. With 83.53K shares outstanding, the current market capitalization sits at 184.17M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AARD showed earnings on August 13, 2025. You can read more about the earnings report here.